Natasha Hernday - 19 Jul 2024 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ James Pennington, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
19 Jul 2024
Net transactions value
$0
Form type
3
Filing time
22 Jul 2024, 20:01:03 UTC
Previous filing
20 May 2024
Next filing
23 May 2025

No securities are beneficially owned.